PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions
Pulmonary Hypertension
Trial Locations (1)

350011

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER

NCT07131241 - PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter